Having trouble accessing articles? Reset your cache.

Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more

Assembly Biosciences Inc. (NASDAQ:ASMB) gained $2.39 (20%) to $14.25 Wednesday after hiring John McHutchison as president and CEO, succeeding Derek Small. Gilead Sciences Inc. (NASDAQ:GILD) announced last month that McHutchison would step down as CSO and head of R&D. Small, who co-founded the HBV company, will return to Luson

Read the full 496 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers